Financhill
Back

Puma Biotechnology Quote, Financials, Valuation and Earnings

Puma Biotechnology Price Quote

$2.91
+0.07 (+2.46%)
(Updated: November 21, 2024 at 5:55 PM ET)

Puma Biotechnology Key Stats

Sell
47
Puma Biotechnology (PBYI) is a Sell

Day range:
$2.66 - $2.86
52-week range:
$2.23 - $7.73
Dividend yield:
0%
P/E ratio:
6.09
P/S ratio:
0.54
P/B ratio:
1.89%

Volume:
270.6K
Avg. volume:
437.1K
1-year change:
-26.99%
Market cap:
$134.5M
Revenue:
$235.6M
EPS:
$0.47

How Much Does Puma Biotechnology Make?

Is Puma Biotechnology Growing As A Company?

  • What Is Puma Biotechnology's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.44%
  • What Is Puma Biotechnology's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 2.42%

Puma Biotechnology Stock Price Performance

What Is Puma Biotechnology 52-Week High & Low?

Puma Biotechnology Price To Free Cash Flow

Is It Risky To Buy Puma Biotechnology?

  • How Much Debt Does Puma Biotechnology Have?
    Total long term debt quarterly is $78.1M
  • How Much Cash Does Puma Biotechnology Have?
    Cash and short term investments quarterly total is $96.7M
  • What Is Puma Biotechnology’s Book Value Per Share?
    Book value per share is 1.45

Is Puma Biotechnology Cash Flow Positive?

  • What Is PBYI Cash Flow From Operations?
    Cash flow from operations (TTM) is $33.8M
  • What Is Puma Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$22.5M
  • What Is Puma Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$26.3M

Puma Biotechnology Return On Invested Capital

  • Is Management Doing A Good Job?
    PBYI return on invested capital is 15.94%
  • What Is Puma Biotechnology Return On Assets?
    ROA measures how assets are converting to revenues and is 10.82%
  • What Is PBYI Return On Equity?
    ROE is a measure of profitability and is 44.22%

Puma Biotechnology Earnings Date & Stock Price

Puma Biotechnology Competitors

Puma Biotechnology Dividend Yield

Puma Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 241.67% 18.42%
Revenue: 43.53% 13.94%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.33
Upside from Last Price: 52.58%

Major Shareholders

  • How many PBYI shares are owned by institutional investors?
    39.9M PBYI shares are owned by institutional investors
  • How many PBYI shares are owned by insiders?
    8.4M PBYI shares are owned by insiders